Growing Demand Driving Growth in the Rescue Inhaler Market


 Rescue inhalers deliver medicine to the airways and provide quick relief from asthma symptoms and chronic obstructive pulmonary disease (COPD) attacks. They contain either albuterol or levalbuterol and act as bronchodilators that relax muscles in the airways to relieve wheezing, coughing, chest tightness, and shortness of breath. The global rescue inhaler market is estimated to be valued at US$ 15.5 Bn in 2023 and is expected to exhibit a CAGR of 8.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Key Trends:

The growing demand for rescue inhalers is one of the major trends accelerating growth in the rescue inhaler market. According to the Centers for Disease Control and Prevention (CDC), around 26 million Americans currently have asthma, and over 16 million Americans have been diagnosed with COPD. The prevalence rates of both asthma and COPD have increased significantly over the past few decades due to increasing environmental pollution and growing tobacco consumption. With the high prevalence of respiratory diseases and growing environmental concerns, the demand for drugs such as rescue inhalers is growing substantially. This is expected to propel the rescue inhaler market forward over the forecast period.
Segment Analysis
The global rescue inhaler market is dominated by the bronchodilator segment, as it holds more than 70% market share. Bronchodilators are preferred medicines and first line of treatment for patients suffering from respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). They work by relaxing and opening the airways of the lungs to provide quick relief from symptoms of asthma attacks or exacerbation of COPD.

Key Takeaways
The global rescue inhaler market is expected to witness high growth over the forecast period of 2023 to 2030. The market size is projected to reach nearly US$ 15.5 Bn by 2024.

Regional analysis
North America currently dominates the rescue inhaler market with over 40% share. Higher prevalence of respiratory diseases, widespread health insurance coverage, availability of advanced products, and presence of prominent market players drive the North America market. The Asia Pacific region is projected to grow at the fastest rate during the forecast period due to rising air pollution levels, growing medical needs of large geriatric population, and increasing healthcare expenditure in countries like China and India.

Key players
Key players operating in the rescue inhaler market are GSK, Merck, Teva Pharmaceutical, and others. GSK holds the leading position with its Ventolin inhaler brand holding more than 50% market share globally. The company mainly focuses on innovations, expanding to emerging markets, and promotional campaigns to strengthen its dominance in the rescue inhaler space.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more